In Europe, life sciences deals increased over the last few years with strong acceleration in 2021. As a result, the market wonders whether this is just an uptick or rather a steady.
/PRNewswire/ Mnemo Therapeutics, a biotechnology company developing next-generation T cell therapies, today announced the appointment of Robert LaCaze as.
/PRNewswire/ Mnemo Therapeutics, a biotechnology company developing next-generation T cell therapies, today announced the appointment of Robert LaCaze as.
Robert LaCaze is taking over the reins of Mnemo Therapeutics with the goal of overcoming key challenges in CAR-T therapies and driving the company’s lead assets into the clinic.